Consequently, the combination of SRF, anti-miRNA 27a, and anti-GPC3 antibodies led to enhanced apoptosis, reduced tumor volume by nearly threefold compared to control, and significant tumor accumulation than in normal tissue.32 The gene discussed is GPC3; the disease is neoplasm.